跳轉至內容
Merck
全部照片(1)

重要文件

810891C

Avanti

DSPE PEG(2000)-N-Cyanine 5

Avanti Research - A Croda Brand, chloroform solution

同義詞:

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000]-N-(Cyanine 5)

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C164H299N4O55P
CAS號碼:
分子量::
3238.10
分類程式碼代碼:
12352211
NACRES:
NA.25
暫時無法取得訂價和供貨情況

化驗

99% (TLC)

形狀

chloroform solution

包裝

pkg of 1 × 1 mg (
810891C-1MG)

pkg of 5 × 1 mg (
810891C-5MG)

製造商/商標名

Avanti Research - A Croda Brand

濃度

1 mg/mL (810891C-1MG)
1 mg/mL (810891C-5MG)

運輸包裝

dry ice

儲存溫度

−20°C

應用

DSPE PEG(2000)-N-Cy5 is suitable for use to ensure the proper insertion of folic acid to red blood cells (RBCs) membrane by fluorescence microscopy.[1]

生化/生理作用

DSPE PEG(2000)-N-Cy5 is used in the preparation of folic acid and Cy5 modified red blood cells (RBCs) vesicles (FRVs).[2] DSPE PEG(2000)-N-Cy5 is used to demonstrate the modification of RBCs membrane with folic acid. After mixing DSPE PEG(2000)-N-Cy5 with RBC, the non-luminous membrane exhibits bright Cy5 fluorescence, enables visualization with fluorescence microscope.[1]

包裝

5ML Clear Glass Sealed Ampule (810891C-1MG)
5ML Clear Glass Sealed Ampule (810891C-5MG)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

象形圖

Skull and crossbonesHealth hazard

訊號詞

Danger

危險分類

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

標靶器官

Central nervous system, Liver,Kidney

儲存類別代碼

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Erythrocyte derived vesicles for circulating tumor cells capturing and specific tumor imaging
Liu A, et al.
Nanoscale, 11, 12388-12396 (2019)
Engineered red blood cells for capturing circulating tumor cells with high performance
Zhu DM, et al.
Nanoscale, 10(13), 6014-6023 (2018)
Ming Chen et al.
Nanoscale, 11(25), 12388-12396 (2019-06-20)
The precise diagnosis of cancer remains a great challenge; therefore, it is our research interest to develop safe, tumor-specific reagents. In this study, we designed nanovesicles derived from erythrocyte membranes; the nanovesicles are capable of recognizing tumor cells for both

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務